Synta drug placed on fast track
16th Nov 2006, 13:24 GMT
Synta Pharmaceuticals Corp. said Wednesday that its drug candidate to treat a serious type of skin cancer has been granted Fast Track designation by the U.S. Food and Drug Administration.
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- Synbiotics flu test gets OK from USDA
- Mesa Lab's numbers up
- Reliance Steel to offer $600M in notes
- Biotech firm expanding, completes office relocation
- Spectrum Pharmaceuticals settles with GlaxoSmithKline
- Study: Bioenergy sugar product useful for chronic fatigue syndrome
- IBT Labs will spend $2M to expand division
- InnoCentive to help push $1M prize for discoveries in ALS
- Mercury, BU team says biotech app cuts processing time to minutes
- Omnicare to pay $49.5M in civil settlement